Magellan Health Inc (NASDAQ:MGLN) Shares Sold by Strs Ohio
Strs Ohio cut its holdings in shares of Magellan Health Inc (NASDAQ:MGLN) by 10.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,500 shares of the company’s stock after selling 1,500 shares during the period. Strs Ohio’s holdings in Magellan Health were worth $1,002,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Arizona State Retirement System boosted its position in shares of Magellan Health by 1.1% during the second quarter. Arizona State Retirement System now owns 37,297 shares of the company’s stock worth $2,769,000 after buying an additional 389 shares during the period. FNY Investment Advisers LLC boosted its position in shares of Magellan Health by 747.0% during the second quarter. FNY Investment Advisers LLC now owns 6,776 shares of the company’s stock worth $502,000 after buying an additional 5,976 shares during the period. Waratah Capital Advisors Ltd. acquired a new position in shares of Magellan Health during the second quarter worth approximately $496,000. Destination Wealth Management acquired a new position in shares of Magellan Health during the second quarter worth approximately $45,000. Finally, CWM Advisors LLC acquired a new position in shares of Magellan Health during the second quarter worth approximately $236,000. Institutional investors and hedge funds own 96.48% of the company’s stock.
MGLN has been the subject of several analyst reports. BidaskClub upgraded Magellan Health from a “sell” rating to a “hold” rating in a research report on Saturday, July 27th. ValuEngine upgraded Magellan Health from a “hold” rating to a “buy” rating in a research report on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Magellan Health currently has a consensus rating of “Hold” and a consensus target price of $74.80.
Magellan Health (NASDAQ:MGLN) last announced its earnings results on Tuesday, July 30th. The company reported $0.86 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.92 by ($0.06). Magellan Health had a return on equity of 3.68% and a net margin of 0.18%. The firm had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.75 billion. During the same period in the previous year, the firm earned $0.92 EPS. Magellan Health’s revenue for the quarter was down 1.3% on a year-over-year basis. On average, equities analysts predict that Magellan Health Inc will post 3.96 earnings per share for the current fiscal year.
Magellan Health Company Profile
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine.
See Also: What is the NASDAQ Stock Market?
Want to see what other hedge funds are holding MGLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Magellan Health Inc (NASDAQ:MGLN).
Receive News & Ratings for Magellan Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health and related companies with MarketBeat.com's FREE daily email newsletter.